Biomerica, Inc.
BMRA
$2.18
$0.020.93%
NASDAQ
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Net Income | 13.94% | 28.19% | 40.68% | 16.81% | 23.61% |
| Total Depreciation and Amortization | 5.34% | 5.15% | 6.86% | 6.95% | 9.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.84% | -31.87% | -18.95% | -24.12% | -49.33% |
| Change in Net Operating Assets | 142.41% | 126.94% | -207.58% | 168.60% | 0.39% |
| Cash from Operations | 24.95% | 40.46% | 45.04% | 28.35% | 20.00% |
| Capital Expenditure | -- | -- | -- | -- | 11.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 48.65% | 91.84% | -68.18% | 42.19% | 52.56% |
| Cash from Investing | 68.85% | 94.52% | 28.85% | 67.83% | 41.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -30.75% | 716.07% | -- | -- | -73.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 70.97% | 30.11% | 18.52% | 41.98% | 80.98% |
| Cash from Financing | -28.35% | 947.83% | 3,841.98% | 2,706.17% | -72.31% |
| Foreign Exchange rate Adjustments | 190.91% | 200.00% | 225.00% | -137.50% | -222.22% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.88% | 103.61% | 104.53% | 68.10% | -214.54% |